Log in to save to my catalogue

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosi...

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_581273

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

About this item

Full title

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

Publisher

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2005-10, Vol.64 (10), p.1421-1426

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

Background: Existing studies of solid cancers in rheumatoid arthritis (RA) reflect cancer morbidity up until the early 1990s in prevalent cohorts admitted to hospital during the 1980s. Objective: To depict the cancer pattern of contemporary patients with RA, from updated risk data from prevalent and incident RA populations. To understand the risk o...

Alternative Titles

Full title

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_581273

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_581273

Other Identifiers

ISSN

0003-4967,1468-2060

E-ISSN

1468-2060

DOI

10.1136/ard.2004.033993